T. Rowe Price US Large Cap Growth Equity
T. Rowe Price US Large Cap Growth Equity fund seeks to invest in large US firms that demonstrate innovation and change. Experienced managers Taymour Tamaddon and Jon Friar collaborate with the T. Rowe Price analyst team to find these names, the best of which they will back with strong conviction. Taymour’s past experience has given him excellent insight and access to some of the world’s leading companies and Jon brings his own specialist experience.
Our Opinion
Fund Managers
Expand
Fund Managers
Close
Taymour Tamaddon, Co-manager Taymour Tamaddon is a co-manager for the US Large-Cap Growth Equity Strategy at T. Rowe Price. As a vice president, he also serves on the Investment Advisory Committees for Health Sciences Equity, Global Growth Equity, US Growth Stock Equity, and Global Focused Growth Equity Strategies. Additionally, Taymour is a member of the firm’s Equity Steering Committee.
Jon Friar, Co-manager Jon joined Taymour on the fund on 1st January 2025, having already been working closely with Taymour as associate portfolio manager on the fund. Jon has 18 years of investment experience and joined T. Rowe Price in 2011, beginning as an analyst covering financial companies. Prior to working at T. Rowe, Jon was in structured product sales at Barclays Capital.
Taymour Tamaddon, Co-manager Taymour Tamaddon is a co-manager for the US Large-Cap Growth Equity Strategy at T. Rowe Price. As a vice president, he also serves on the Investment Advisory Committees for Health Sciences Equity, Global Growth Equity, US Growth Stock Equity, and Global Focused Growth Equity Strategies. Additionally, Taymour is a member of the firm’s Equity Steering Committee.
Read More
Jon Friar, Co-manager Jon joined Taymour on the fund on 1st January 2025, having already been working closely with Taymour as associate portfolio manager on the fund. Jon has 18 years of investment experience and joined T. Rowe Price in 2011, beginning as an analyst covering financial companies. Prior to working at T. Rowe, Jon was in structured product sales at Barclays Capital.
Read More
Risk
Read more
Back
Company Description
Read more
Back
Fund Performance
Close
Risk
Close
Company Description
Close
Quote from the Fund Manager
The US equity market is largely efficient (!) so we need to embrace uncertainty and use research to identify likely beneficiaries of disruption that have the best management teams with the most profitable future business models.
Taymour Tamaddon
Co-manager
Investment process
T. Rowe Price US Large Cap Growth Equity is one of the more concentrated portfolios at T. Rowe Price. Taymour and Jon look for companies that can generate above average growth for the next three to five years, determined by how much free cash flow they can produce. They believe that most large-cap growth companies revert to the mean over time, so want to capture outperformance in that period. They are happy to have a small part of the portfolio in firms exhibiting lower but sustainable growth.
The managers can choose from a universe of approximately 500 companies. This universe is first analysed with a screen, which looks for a minimum of 10% + inflation earnings growth. Taymour and Jon recognise that this is a high benchmark and whittle the list down to around 150-200 companies.
From here, T. Rowe Price’s analyst team do their proprietary fundamental analysis. This will involve going through the stock’s financial reports to confirm the screens have interpreted the company’s numbers correctly and looking for where the company is performing and whether it is able to grow into the future. T. Rowe Price has an enviable resource of equity specialists to help produce this work.
Taymour and Jon will then stress test the stock’s investment thesis to confirm the analysts’ expectations. They do this in partnership with the analyst, making sure they have done the work on the stock too, not simply picked their best ideas. Work is conducted on ESG inputs at this stage too. There will then be a valuation analysis to assess the estimation of what is a good price for the stock. This leaves around 80-100 companies that are worthy of consideration.
The final portfolio will consist of around 60-75 companies that have been selected based on which make for the most compelling opportunities over a three-year period, as well as the risk they offer. The top ten stocks will be high conviction and account for around 50% of the portfolio. A more even spread and smaller weightings across the remaining 50+ stocks helps with risk management through diversification, without sacrificing potential rewards.
Risk
Alongside the risk assessment inherent in fundamental analysis, the managers have a ±5% relative position limit to the Russell 1000 Growth index. There are sector limits too: Taymour and Jon cannot have less than half the benchmark weight of a sector, nor more than three times its weight. They also can’t buy anything the small and medium-sized funds team own. The fund has done well in a variety of markets but has underperformed when value stocks have outperformed.
ESG
ESG - Integrated
For Taymour, Jon and the team, ESG factors are one component of the investment decision, meaning that they are not the sole driver of an investment decision, nor are they considered separately from more traditional analysis. Rather, they enhance investment decisions. In order to systematically evaluate ESG factors, the investment team follows a three-step process - identification, analysis and integration. It will initially use ESG screening tools (including a proprietary ESG scoring model, Responsible Investing Indicator Model (RIIM)) to identify companies with ESG issues. T. Rowe’s team of dedicated ESG specialists will then apply further analysis to companies flagged by the screening process, which can include engagement initiatives and proxy voting recommendations.
The process allows Taymour and Jon to understand any ESG risks present in the portfolio and to integrate the analysis into their investment strategy. The main ESG focuses are Responsible Investing (RI) and Governance.
The information, data, analyses, and opinions contained herein (1) include the proprietary information of FundCalibre, (2) may not be copied or redistributed without prior permission, (3) do not constitute investment advice offered by FundCalibre, (4) are provided solely for informational purposes and therefore are not an offer to buy or sell a fund, and (5) are not warranted to be correct, complete, or accurate. FundCalibre shall not be responsible for any trading decisions, damages, or other losses resulting from, or related to, this information, data, analyses, or opinions or their use. The Elite Fund rating is subjective in nature and reflects FundCalibre’s current expectations of future events/behaviour as they relate to a particular fund. Because such events/behaviour may turn out to be different than expected, FundCalibre does not guarantee that a fund will perform in line with its FundCalibre benchmark. Likewise, the Elite Fund rating should not be seen as any sort of guarantee or assessment of the creditworthiness of a fund nor of its underlying securities and should not be used as the sole basis for making any investment decision. FundCalibre disclaims any responsibility for trading decisions, damages or other losses resulting from any use of the Elite Fund rating. All performance data, as well as fund size, OCF, AMC, annual income (historic), share price discount or premium, is sourced directly from FE Analytics, and will change periodically.